Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma. [electronic resource]
Producer: 20150521Description: 27-32 p. digitalISSN:- 1096-0945
- Adenocarcinoma -- drug therapy
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Female
- Follow-Up Studies
- Gene Expression Regulation, Neoplastic
- Humans
- Immunoenzyme Techniques
- Loss of Heterozygosity
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Grading
- Neoplasm Invasiveness
- Neoplasm Staging
- PTEN Phosphohydrolase -- genetics
- Phosphatidylinositol 3-Kinases -- metabolism
- Polymerase Chain Reaction
- Prognosis
- Proto-Oncogene Proteins c-akt -- metabolism
- Signal Transduction
- Survival Rate
- TOR Serine-Threonine Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.